Richard W Schevitz from 7040 Eastwick Ln, Indianapolis, IN 46256, age 82

Substituted Tricyclics
view source
US Patent:

6713645, Mar 30, 2004
Filed:

Oct 13, 2000
Appl. No.:

09/688106
Inventors:

Nicholas James Bach - Indianapolis IN
Susan Elizabeth Draheim - Indianapolis IN
Robert Delane Dillard - Zionsville IN
Edward David Mihelich - Carmel IN
Jason Scott Sawyer - Indianapolis IN
Douglas Wade Beight - Frankfort IN
Michael LeRoy Phillips - Indianapolis IN
Tulio Suarez - Greenwood IN
Daniel Jon Sall - Greenwood IN
Jolie Anne Bastian - Beech Grove IN
Michael Lyle Denney - Franklin IN
Gary Alan Hite - Indianapolis IN
Michael Dean Kinnick - Indianapolis IN
Robert Theodore Vasileff - Indianapolis IN
Ho-Shen Lin - Indianapolis IN
Michael Enrico Richett - Indianapolis IN
Richard Waltz Harper - Indianapolis IN
Benjamin Alan Anderson - Zionsville IN
Nancy Kay Harn - Indianapolis IN
Richard James Loncharich - Carmel IN
Richard Walter Schevitz - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

C07C 6976
US Classification:

560 8
Abstract:

A class of novel tricyclics is disclosed together with the use of such compounds for inhibiting sPLA mediated release of fatty acids for treatment of conditions such as septic shock.

1H-Indole-3-Acetic Acid Hydrazide Spla.sub.2 Inhibitors
view source
US Patent:

55786340, Nov 26, 1996
Filed:

May 12, 1995
Appl. No.:

8/440154
Inventors:

Nicholas J. Bach - Indianapolis IN
Robert D. Dillard - Zionsville IN
Susan E. Draheim - Indianapolis IN
Robert B. Hermann - Indianapolis IN
Richard W. Schevitz - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

C07D20918
C07D40306
A61K 31405
A61K 3141
US Classification:

514419
Abstract:

A class of novel 1H-indole-3-acetic acid hydrazides is disclosed together with the use of such indole compounds for inhibiting sPLA. sub. 2 mediated release of fatty acids (e. g. , arachidonic acid) for treatment of conditions such as septic shock.

Substituted Tricyclics
view source
US Patent:

61774405, Jan 23, 2001
Filed:

Apr 21, 1998
Appl. No.:

9/063066
Inventors:

Nicholas James Bach - Indianapolis IN
Susan Elizabeth Draheim - Indianapolis IN
Robert Delane Dillard - Zionsville IN
Edward David Mihelich - Carmel IN
Jason Scott Sawyer - Indianapolis IN
Douglas Wade Beight - Frankfort IN
Michael LeRoy Phillips - Indianapolis IN
Tulio Suarez - Greenwood IN
Daniel Jon Sall - Greenwood IN
Jolie Anne Bastian - Beech Grove IN
Michael Lyle Denney - Franklin IN
Gary Alan Hite - Indianapolis IN
Michael Dean Kinnick - Indianapolis IN
Robert Theodore Vasileff - Indianapolis IN
John Michael Morin - Brownsburg IN
Ho-Shen Lin - Indianapolis IN
Michael Enrico Richett - Indianapolis IN
Richard Waltz Harper - Indianapolis IN
John McNeill McGill - Greenwood IN
Benjamin Alan Anderson - Zionsville IN
Nancy Kay Harn - Indianapolis IN
Richard James Loncharich - Carmel IN
Richard Walter Schevitz - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

A61K 3144
A61K 3140
C07D47100
C07D49100
C07D491052
US Classification:

514292
Abstract:

A class of novel tricyclics is disclosed together with the use of such compounds for inhibiting sPLA. sub. 2 mediated release of fatty acids for treatment of conditions such as septic shock.

1H-Indole-3-Acetamide Spla2 Inhibitors
view source
US Patent:

62520849, Jun 26, 2001
Filed:

Oct 31, 1997
Appl. No.:

8/962603
Inventors:

Nicholas J. Bach - Indianapolis IN
Robert D. Dillard - Zionsville IN
Susan E. Draheim - Indianapolis IN
Robert B. Hermann - Indianapolis IN
Richard W. Schevitz - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

C07F 938
C07D20910
C07D20914
C07D40306
US Classification:

548113
Abstract:

A class of novel 1H-indole-3-acetamides is disclosed together with the use of such indole compounds for inhibiting sPLA. sub. 2 mediated release of fatty acids for treatment of conditions such as septic shock.

1H-Indole-3-Acetamide Spla.sub.2 Inhibitors
view source
US Patent:

56840349, Nov 4, 1997
Filed:

May 5, 1995
Appl. No.:

8/435256
Inventors:

Nicholas J. Bach - Indianapolis IN
Robert D. Dillard - Zionsville IN
Susan E. Draheim - Indianapolis IN
Robert B. Hermann - Indianapolis IN
Richard W. Schevitz - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

A61K 3140
C07D20912
US Classification:

514419
Abstract:

A class of novel 1-indole-3-acetamides represented by the formula; ##STR1## is disclosed together with the use of such indole compounds for inhibiting sPLA. sub. 2 mediated release of fatty acids.

Richard W Schevitz